DAIHAN Scientific Co. Ltd (131220) — Capital Reinvestment Ratio
Latest as of September 2025:
0.48x
DAIHAN Scientific Co. Ltd (131220) has a Capital Reinvestment Ratio of 0.48x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩361.12 Million) in capital expenditures (₩174.87 Million). See 131220 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.48x
Capex / Operating Cash Flow
Operating Cash Flow
₩361.12 Million
KRW
Capital Expenditures
₩174.87 Million
KRW
Data as of
Sep 2025
Most recent filing
DAIHAN Scientific Co. Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks DAIHAN Scientific Co. Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for DAIHAN Scientific Co. Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for DAIHAN Scientific Co. Ltd from 2012 to 2024. For live market cap and broader valuation context, see DAIHAN Scientific Co. Ltd (131220) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.12x | ₩3.99 Billion | ₩494.10 Million | ▼ -8.0% |
| 2023 | 0.13x | ₩4.79 Billion | ₩645.76 Million | ▼ -80.0% |
| 2022 | 0.67x | ₩4.51 Billion | ₩3.04 Billion | ▼ -12.8% |
| 2021 | 0.77x | ₩4.13 Billion | ₩3.19 Billion | ▲ +317.8% |
| 2020 | 0.18x | ₩5.35 Billion | ₩988.48 Million | ▼ -52.0% |
| 2019 | 0.39x | ₩2.44 Billion | ₩939.56 Million | ▼ -14.5% |
| 2018 | 0.45x | ₩3.76 Billion | ₩1.69 Billion | ▲ +199.4% |
| 2017 | 0.15x | ₩4.58 Billion | ₩689.55 Million | ▲ +4.2% |
| 2016 | 0.14x | ₩4.12 Billion | ₩595.73 Million | ▼ -88.3% |
| 2015 | 1.23x | ₩898.12 Million | ₩1.11 Billion | ▲ +644.7% |
| 2014 | 0.17x | ₩2.59 Billion | ₩429.31 Million | ▼ -89.7% |
| 2012 | 1.61x | ₩565.94 Million | ₩909.46 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow